The C-Suite is the exclusive domain of CEO’s both local and global with an emphasis on Company Results.
Group Chief Executive of Sanlam Paul Hanratty is in the C-SUITE
Group Chief Executive of Sanlam Paul Hanratty is in the C-SUITE Speaking on the announcement of Sanlam Group's Full year results Group CEO Paul Hanratty said "It's been an incredibly difficult 12month period but we are optimistic that the environment will start improving from late 2023 to early 2024 and then we are ready to go! " Watch more episodes of the C-Suite.
Top CEO says South Africa’s Grey-Listing is just another own goal in a long list of own goals.
Top CEO says South Africa's Grey-Listing is just another own goal in a long list of own goals. Momentum Metropolitan CEO Hillie Meyer on the announcement of the company's half year results stresses how difficult it is to do business in South africa whether you are a large corporate, an SME or a consumer. Meyer says Momentum Metropolitan stands ready to help solve the country's problems if Government extends a hand. Watch all our videos for In The C-Suite.
The Johannesburg Stock Exchange (JSE) delivers record trading continuity and systems uptime
The Johannesburg Stock Exchange (JSE) delivers record trading continuity and systems uptime The JSE recorded revenue growth across its business segments with a growing contribution from non trading revenue which was up 13% percent for the period and now contributes 25% to overall revenue. The Resilience of the exchange from an operations perspective is holding strong with uptime of systems and trading continuity at an all time high. Watch all our videos for In The C-Suite.
Nedbank Group sees another hike in South African interest rates with Prime hitting a high of 11%
Nedbank Group sees another hike in South African interest rates with Prime hitting a high of 11% Nedbank reported a stellar set of full year results today for the year ended December 2022. The Group is backing its own business with plans for a R5bn share buyback scheme subject to regulatory approval. Nedbank Group Chief Financial Offer Mike Davis says the bank expects another 25 basis point rate hike in South African with prime peaking at 11% and that this together...
PSG Asset Management wins big at the Raging Bull awards – CIO Greg Hopkins joins us in the C-SUITE
PSG Asset Management wins big at the Raging Bull awards - CIO Greg Hopkins joins us in the C-SUITE PSG Asset Management won South African Manager of the Year award at the Raging Bull Awards for performance to the end of 2022. We spend some time talking to Greg Hopkins who as Chief Investment Officer leads the investment team and we get to grips with his current views of the investment landscape both local and global. Hopkins says that if you...
Understanding the Investment Case for Murray & Roberts after losing its Australian Businesses
Understanding the Investment Case for Murray & Roberts after losing its Australian Businesses Murray & Roberts was hard hit by the pandemic. Today the Group looks very different to its pre Covid structure. CEO Henry Laas takes time to explain the what, where and how of Murray and Roberts as it stands today. The investment case? Well Laas says for new investors the stock is trading at 2.20 /2.30 and the Net Asset Value is R5.00 a share. Notwithstanding that the group...
Harmony Gold holds back on dividend stating a capital intensive phase for the Gold Miner
Harmony Gold holds back on dividend stating a capital intensive phase for the Gold Miner Harmony Gold reported strong half year results recording double digit profits. CEO Peter Steenkamp stressed that the board decided not to declare a dividend as the group is heavily investing in its future and does not want to scramble for money down the line. Steenkamp stressed that ultimately Harmony is intent on being a dividend payer. Watch all our videos for In The C-Suite.
Aspen Pharmacare’s investment case is largely underpinned by the Group’s manufacturing facility
Aspen Pharmacare's investment case is largely underpinned by the Group's manufacturing facility Aspen Pharmacare's sterile manufacturing facility is expected to add R2bn from a contribution perspective in 2024 and R4bn in 2025 as the Group benefits from its significant manufacturing capacity. Aspen Pharmacare Group CEO Stephen Saad is in the C-SUITE and as upbeat as ever despite the tough operating environment that hit the group hard in it's first half results reported earlier today . Watch all our videos for In The...